Literature DB >> 28485080

PELP1: a key mediator of oestrogen signalling and actions in the brain.

R Thakkar1, G R Sareddy2, Q Zhang1, R Wang3, R K Vadlamudi2, D Brann1.   

Abstract

Proline-, glutamic acid- and leucine-rich protein 1 (PELP1) is an oestrogen receptor (ER) coregulator protein identified by our collaborative group. Work from our laboratory and others has shown that PELP1 is a scaffold protein that interacts with ERs and kinase signalling factors, as well as proteins involved in chromatin remodelling and DNA repair. Its role in mediating 17β-oestradiol (E2 ) signalling and actions has been studied in detail in cancer cells, although only recently has attention turned to its role in the brain. In this review, we discuss the tissue, cellular and subcellular localisation of PELP1 in the brain. We also discuss recent evidence from PELP1 forebrain-specific knockout mice demonstrating a critical role of PELP1 in mediating both extranuclear and nuclear ER signalling in the brain, as well as E2 -induced neuroprotection, anti-inflammatory effects and regulation of cognitive function. Finally, the PELP1 interactome and unique gene network regulated by PELP1 in the brain is discussed, especially because it provides new insights into PELP1 biology, protein interactions and mechanisms of action in the brain. As a whole, the findings discussed in the present review indicate that PELP1 functions as a critical ER coregulator in the brain to mediate E2 signalling and actions.
© 2017 British Society for Neuroendocrinology.

Entities:  

Keywords:  PELP1; brain; coregulator; neuroprotection; oestrogen; signalling

Mesh:

Substances:

Year:  2018        PMID: 28485080      PMCID: PMC5785553          DOI: 10.1111/jne.12484

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  76 in total

1.  Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis.

Authors:  Zinovia Kefalopoulou; Vassiliki Tzelepi; Vassiliki Zolota; Petros D Grivas; Christos Christopoulos; Haralabos Kalofonos; Theodoros Maraziotis; Georgia Sotiropoulou-Bonikou
Journal:  J Neurooncol       Date:  2011-07-07       Impact factor: 4.130

2.  Cloning, distribution, and colocalization of MNAR/PELP1 with glucocorticoid receptors in primate and nonprimate brain.

Authors:  Mohammad M Khan; Martin Hadman; Liesl M De Sevilla; Virendra B Mahesh; Jerry Buccafusco; William D Hill; Darrell W Brann
Journal:  Neuroendocrinology       Date:  2006-12-01       Impact factor: 4.914

3.  PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.

Authors:  Valerie Cortez; Cathy Samayoa; Andrea Zamora; Lizatte Martinez; Rajeshwar R Tekmal; Ratna K Vadlamudi
Journal:  Cancer Res       Date:  2014-11-06       Impact factor: 12.701

Review 4.  PELP1: A novel therapeutic target for hormonal cancers.

Authors:  Dimple Chakravarty; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  IUBMB Life       Date:  2010-03       Impact factor: 3.885

5.  Identifying the estrogen receptor coactivator PELP1 in autophagosomes.

Authors:  Kazufumi Ohshiro; Suresh K Rayala; Seiji Kondo; Amitabh Gaur; Ratna K Vadlamudi; Adel K El-Naggar; Rakesh Kumar
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

Review 6.  Emerging significance of estrogen cancer coregulator signaling in breast cancer.

Authors:  M Mann; S Krishnan; R K Vadlamudi
Journal:  Minerva Ginecol       Date:  2012-02

7.  GPR30 mediates estrogen rapid signaling and neuroprotection.

Authors:  Hui Tang; Quanguang Zhang; Licai Yang; Yan Dong; Mohammad Khan; Fang Yang; Darrell W Brann; Ruimin Wang
Journal:  Mol Cell Endocrinol       Date:  2014-03-01       Impact factor: 4.102

8.  NLRP3 Inflammasome Activation in the Brain after Global Cerebral Ischemia and Regulation by 17β-Estradiol.

Authors:  Roshni Thakkar; Ruimin Wang; Gangadhara Sareddy; Jing Wang; Dharma Thiruvaiyaru; Ratna Vadlamudi; Quanguang Zhang; Darrell Brann
Journal:  Oxid Med Cell Longev       Date:  2016-10-23       Impact factor: 6.543

9.  The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype.

Authors:  Hany Onsy Habashy; Desmond G Powe; Emad A Rakha; Graham Ball; R Douglas Macmillan; Andrew R Green; Ian O Ellis
Journal:  Breast Cancer Res Treat       Date:  2009-06-03       Impact factor: 4.872

10.  Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.

Authors:  A R Daniel; A L Gaviglio; T P Knutson; J H Ostrander; A B D'Assoro; P Ravindranathan; Y Peng; G V Raj; D Yee; C A Lange
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867

View more
  5 in total

1.  PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.

Authors:  Yiliao Luo; Mengxing Li; Uday P Pratap; Suryavathi Viswanadhapalli; Junhao Liu; Prabhakar P Venkata; Kristin A Altwegg; Bridgitte E Palacios; Xiaonan Li; Yihong Chen; Manjeet K Rao; Andrew J Brenner; Gangadhara R Sareddy; Ratna K Vadlamudi
Journal:  Mol Carcinog       Date:  2019-12-24       Impact factor: 4.784

2.  The Synthetic Steroid Tibolone Decreases Reactive Gliosis and Neuronal Death in the Cerebral Cortex of Female Mice After a Stab Wound Injury.

Authors:  Andrea Crespo-Castrillo; Natalia Yanguas-Casás; Maria Angeles Arevalo; Iñigo Azcoitia; George E Barreto; Luis M Garcia-Segura
Journal:  Mol Neurobiol       Date:  2018-03-26       Impact factor: 5.590

3.  Comparative Analysis of MicroRNA and mRNA Profiles of Sperm with Different Freeze Tolerance Capacities in Boar (Sus scrofa) and Giant Panda (Ailuropoda melanoleuca).

Authors:  Ming-Xia Ran; Ying-Min Zhou; Kai Liang; Wen-Can Wang; Yan Zhang; Ming Zhang; Jian-Dong Yang; Guang-Bin Zhou; Kai Wu; Cheng-Dong Wang; Yan Huang; Bo Luo; Izhar Hyder Qazi; He-Min Zhang; Chang-Jun Zeng
Journal:  Biomolecules       Date:  2019-09-01

4.  PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling.

Authors:  Gangadhara R Sareddy; Uday P Pratap; Suryavathi Viswanadhapalli; Prabhakar Pitta Venkata; Binoj C Nair; Samaya Rajeshwari Krishnan; Siyuan Zheng; Andrea R Gilbert; Andrew J Brenner; Darrell W Brann; Ratna K Vadlamudi
Journal:  Neurooncol Adv       Date:  2019-11-05

5.  Cromolyn platform suppresses fibrosis and inflammation, promotes microglial phagocytosis and neurite outgrowth.

Authors:  Yi-Jun Wang; Matthew A Downey; Sungwoon Choi; Timothy M Shoup; David R Elmaleh
Journal:  Sci Rep       Date:  2021-11-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.